Jeffrey Reese

Inhibition of cyclooxygenase isoforms in late- but not midgestation decreases contractility of the ductus arteriosus and prevents postnatal closure in mice.

Regulation of the fetal mouse ductus arteriosus is dependent on interaction of nitric oxide and COX enzymes in the ductal wall.

Inadvertent relaxation of the ductus arteriosus by pharmacologic agents that are commonly used in the neonatal period.

Substrate-selective COX-2 inhibition decreases anxiety via endocannabinoid activation.

Embryonic domains of the aorta derived from diverse origins exhibit distinct properties that converge into a common phenotype in the adult.

Aminoglycoside-mediated relaxation of the ductus arteriosus in sepsis-associated PDA.

The Patent Ductus Arteriosus Problem: Infants Who Still Need Treatment.

Prophylactic Indomethacin Revisited.

Reflections on the early years of neonatology. Paul R. Swyer: the beginnings of Canadian neonatology at The Hospital for Sick Children in Toronto and insights into his early career.

Genetics of the patent ductus arteriosus (PDA) and pharmacogenetics of PDA treatment.

Striking parallels between carotid body glomus cell and adrenal chromaffin cell development.

Towards a greater understanding of the ductus arteriosus.

Transcriptional profiling of the ductus arteriosus: Comparison of rodent microarrays and human RNA sequencing.

Reflections on the early years of neonatology. William Oh: neonatal pioneer devoted his career to groundbreaking research, expanding patient care, and mentoring others.

Inactivation of in Abcg2 lineage-derived cells drives the appearance of polycystic lesions and fibrosis in the adult kidney.

Fetal exposure to maternal inflammation interrupts murine intestinal development and increases susceptibility to neonatal intestinal injury.